The preparation of lyophilized powder is a sterile manufacturing process that utilizes freeze-drying technology to remove moisture under low-temperature and vacuum conditions, thereby yielding a dry powder product.
The entire workflow can be broadly divided into three major stages: pre-lyophilization preparation, the freeze-drying process, and post-lyophilization processing. Pre-lyophilization preparation involves buffer exchange, concentration, and aseptic filling; specifically, the medicinal solution's original buffer must be exchanged for a solution containing a lyoprotectant. Commonly used lyoprotectants include simple sugars (such as trehalose, sucrose, and mannitol), proteins (such as human serum albumin), and polymers (such as dextran and polyvinylpyrrolidone).
The freeze-drying process consists of three phases: pre-freezing, primary drying, and secondary drying. Pre-freezing involves completely solidifying the sample; methods for achieving this include programmed cooling and rapid freezing. Primary drying involves the sublimation of ice under vacuum conditions; the vacuum level is typically set within the range of 10 to 100 Pa, and the shelf temperature must be carefully controlled to rise gradually. Secondary drying involves raising the shelf temperature-while maintaining the vacuum-to remove residual bound water.
Post-lyophilization processing encompasses nitrogen backfilling, stopper insertion, and sealing. Upon completion of the drying phase, the freeze-drying chamber is backfilled with dry, sterile nitrogen or an inert gas. The vials are then stoppered and sealed with aluminum caps within this vacuum or inert gas environment; storage under low-temperature conditions and away from light is recommended.
Key parameters for process control include shelf temperature, heating and cooling rates, and vacuum levels. During primary drying, the temperature must be maintained at a level 5 to 10°C below the material's glass transition temperature or eutectic point to prevent structural collapse.
Production must be conducted within a sterile environment; specifically, the media fill validation test-a critical component of sterile process validation-serves as the primary means for assessing and confirming the level of sterility assurance.